Mosby’s Nursing Drug Reference is a clinical pharmacology tool for nursing students and clinicians, providing drug monographs and medical calculators on iOS and Android.
The App DNA
What makes this app unique?
Users hire this app to minimize medication dispensing errors through verified safety alerts, replacing the need for bulky printed handbooks during clinical rotations.
For Nursing students and practicing clinicians requiring rapid, evidence-based drug information and safety alerts during clinical rotations.
Key features
Access to 5,000+ generic and trade name drug profiles including FDA-approved entries
Visual indicators for critical interactions and side effects within drug monographs
26 specialized medical calculators for clinical decision support
How much does it cost?
Subscription model anchored at $44.99/year, gating full clinical database access behind an annual recurring payment.
Velocity
Steady developmentShow more...
Who built it?
Skyscape Medpresso
13+ apps tracked · Medical
Saunders Comp Review NCLEX RN
Nursing Constellation Plus+
Essential Guide to Acute Care
Emergency Medicine On Call
Swanton's Cardiology
Washington Manual Ob Gy Guide
Handbook Clinical Anesthesia
Mosby's Pocket Dictionary
Goodheart Skin Disorders
CURRENT Dx Tx Occupational
AHFS Drug Information
DDx in Small Animal MedicineUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Mosby’s Nursing Drug Reference
How's the Medical market?
The app maintains a #80 Grossing rank in the US Medical category, but the 3.4-star rating on Android indicates significant friction compared to the iOS experience. This performance gap suggests that technical instability on Android is actively eroding the app's professional credibility.
Read the market outlookThe rivals identified
By Unbound Medicine, Inc.
This is the most direct competitor, offering a comprehensive nursing-specific drug reference suite that mirrors this app's core value proposition.
- Integrates multiple nursing-specific databases beyond just drug references into a single unified clinical workflow tool.
- Provides cross-linked access to disease, test, and procedure information which this app currently lacks.
- Maintains a consistent, high-frequency update cycle for clinical content that builds long-term professional trust.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Mosby’s Nursing Drug Reference
Where is it heading?
The medical reference market is consolidating around free, multi-disciplinary platforms that offer broader utility than standalone drug guides. Mosby's must transition from a static reference tool to a workflow-integrated clinical assistant to prevent further user migration to all-in-one competitors.
- Android technical instability (3.4 rating) creates a barrier to professional adoption, which compounds the churn risk against free competitors.
- The addition of 35 FDA-approved monographs demonstrates active clinical content maintenance, which sustains the app's value for current subscribers.
The SWOT
- Safety Alert icons function as a clinical trust moat
- Nursing Process framework aligns with academic curriculum requirements
- Integration of wearable-based clinical alerts
- B2B partnerships with nursing schools for bulk license distribution
Next best moves
Rebuild Android core to match iOS stability because the 3.4 rating indicates technical churn → recover Android user base
+ 1 more prioritized moveThe counter-intuitive read
The app's lack of broader diagnostic content is a feature, not a bug…
Read the full takeFeature gaps
Cross-linked disease and diagnostic references (available in Nursing Central but absent here) +1
Since the last report: The app has transitioned to a rigid $44.99 annual subscription model while facing significant technical instability on Android, which is eroding its competitive standing against free, multi-disciplinary clinical tools.
Bottom line
The app maintains clinical authority through specialized safety alerts, but the high $44.99 price point and Android technical instability invite migration to free alternatives, so the PM must prioritize platform parity to defend the existing user base.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated